Clinical Trial of Investigational Ebola Treatments Begins in the Democratic Republic of the Congo
This randomized control trial will test multiple investigational Ebola therapies in the Democratic Republic of the Congo (DRC). The study is being run by WHO and NIH and taking place at treatment facilities managed by ALIMA, MSF, and IMC in DRC. The Humanitarian Innovation Initiative is supporting its implementation with technical and research expertise.
November 27, 2018 National Institute of Allergy and Infectious Disease